Anti-tau vaccine is successful in clinical trial for people with Alzheimer's disease.
Alzheimer's disease progressively impairs cognition and daily function, and death usually occurs five to ten years after diagnosis. There are drugs available to treat the disease's symptoms, but they do not halt or slow its progression.